Craneware (LON:CRW) Sets New 52-Week Low – What’s Next?

Craneware plc (LON:CRW)’s stock price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 1,272.30 and last traded at GBX 1,290, with a volume of 148683 shares trading hands. The stock had previously closed at GBX 1,331.16.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Berenberg Bank reiterated a “buy” rating and set a GBX 2,900 target price on shares of Craneware in a research note on Tuesday, January 20th. Shore Capital Group restated a “buy” rating and issued a GBX 2,850 price target on shares of Craneware in a research note on Tuesday, January 20th. Finally, UBS Group reaffirmed a “buy” rating and set a GBX 570 price target on shares of Craneware in a report on Wednesday, March 25th. Four analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of GBX 2,297.75.

Craneware Stock Performance

The firm has a market cap of £458.07 million, a price-to-earnings ratio of 23.37 and a beta of 0.28. The company has a current ratio of 0.76, a quick ratio of 1.00 and a debt-to-equity ratio of 7.93. The stock’s 50 day moving average is GBX 1,523.15 and its 200 day moving average is GBX 1,927.10.

Craneware Company Profile

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.